|
 |
75  |
total results, including |
0  |
0  |
3  |
|
|
|
|
|
Open all preview windows |
1.

|
Central Nervous System Agents - Central Nervous System Drugs - information page with HONselect
Open preview window
... They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. ... Nootropic Agents
... [05/09/07]
http://www.hon.ch/HONselect/Selection/D15.html |
Open link in new window | More pages from www.hon.ch
|
 |
3.

|
CNS Drug Discoveries: What the future holds
Open preview window
... Nootropic drugs or anti-Alzheimer's drugs are one of the largest segments of the neurodegenerative market and accounted for 33% of global sales (US$2.6 billion in 2003 and equivalent to 4% of global CNS drug sales). ... These include the development of antidepressants (Cymbalta), antiepileptic agents (Lyrica and Prialt) glutamate antagonists (Namenda, Lamictal ... [24/01/07]
http://www.leaddiscovery.co.uk/reports/CNS-Drug-Discoveries.html |
Open link in new window | More pages from www.leaddiscovery.co.uk
|
 |
4.

|
BioPortfolio Bulletin - CNS Disorders Alzheimer's Disease Multiple Sclerosis Attention Deficit Hyperactivity Disorder (ADHD), Insomnia, Depression, Neuropathic
Open preview window
... Nootropic drugs or anti-Alzheimer's drugs are one of the largest segments of the neurodegenerative market and accounted for 33% of global sales (US$2.6 billion in 2003 and equivalent to 4% of global CNS drug sales). ... These include the development of antidepressants (Cymbalta), antiepileptic agents (Lyrica and Prialt) glutamate antagonists (Namenda, Lamictal ... [10/10/06]
http://www.bioportfolio.co.uk/bulletin_59.htm |
Open link in new window | More pages from www.bioportfolio.co.uk
|
 |
5.

|
Emerging Alzheimer's Disease Therapeutics
Open preview window
... The classes of therapeutics currently indicated for the treatment of Alzheimer's disease (AD) are used either to slow disease progression (e.g., acetyl cholinesterase inhibitors and NMDA/glutamate receptor antagonists) or to alleviate cognitive symptoms (e.g., carnitine acetyltransferase stimulatnts and nootropic agents). ... [23/11/07]
http://www.piribo.com/publications/diseases_conditions/alzheimers/nav001.html |
Open link in new window | More pages from www.piribo.com
|
 |
6.

|
Focus on Vinpocetine
Open preview window
... (1992) Effects of aspirin, dipyridamole, nifedipine, and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination. ... (1986) Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats. ... [22/05/07]
http://www.priory.com/focus15.htm |
Open link in new window | More pages from www.priory.com
|
 |
7.

|
Dictionary Contents: N
Open preview window
... n; n0; N10-formyltetrahydrofolate; N1-acetylsulfanilamide; N/2; N(2),N(2)-dimethylguanosine-26-methyltransferase; N(2),N(2)-dimethylguanosine-specific tRNA methyltransferase; N(2)-succinylarginine dihydrolase; N(2)-succinylornithine 5-aminotransferase; N4-acetylsulfanilamide; N-(5-amino-1-ribosyl-4-imidazolylcarbonyl)-L-aspartic acid 5'-phosphate syntheta ... [30/03/07]
http://cancerweb.ncl.ac.uk/omd/contents/N.html |
Open link in new window | More pages from cancerweb.ncl.ac.uk
|
 |
8.

 |
Selegiline - Wikipedia
Open preview window
Selegiline
/ From Wikipedia
/ Jump to: navigation, search
/ Image:Selegiline-structure.png
/ Selegiline
/ N-methyl-1-phenyl-N-prop-2-ynyl-propan-2-amine
... It is sometimes used off-label to treat narcolepsy and as a nootropic, as well as for its purported life-extending effects. ... Antiparkinsonian agents [25/04/06]
http://en.wikipedia.org/wiki/Selegiline |
Open link in new window | More pages from en.wikipedia.org
|
 |
9.

|
PROVIGIL/MODAFINIL: Manufacturer's Insert: Approved Uses
Open preview window
Welcome to IAS
/ Home
/ Contact Us
/ Product
/ Special Offers
/ Store
... Psychostimulant and nootropic agents. ... Whilst studies carried out with modafinil and other psychoactive agents have shown a low dependence potential, the possibility of dependence following prolonged use cannot be entirely ruled out. ... [16/08/07]
http://www.antiaging-systems.com/apruses/provigil.htm |
Open link in new window | More pages from www.antiaging-systems.com
|
 |
|
|
|
|
|
|
|